Vasculitis in systemic lupus erythematosus following intravenous immunoglobulin therapy

Clinical and Experimental Rheumatology

Volumn 14, Issue 6, 1996, Pages 673-675

  Hashkes, P J ^a   Lovell, D J ^a  

^a CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

Author keywords

intravenous immunoglobulin; systemic lupus erythematosus; vasculitis

Indexed keywords

ANCROD; DANAZOL; GLYCERYL TRINITRATE; HEPARIN; IMMUNOGLOBULIN G; METHYLPREDNISOLONE; PREDNISONE; VERAPAMIL;

ARTICLE; CASE REPORT; FEMALE; HUMAN; IDIOPATHIC THROMBOCYTOPENIC PURPURA; INTRAVENOUS DRUG ADMINISTRATION; PRESCHOOL CHILD; PRIORITY JOURNAL; SYSTEMIC LUPUS ERYTHEMATOSUS; VASCULITIS;

AMPUTATION; CHILD; DRUG THERAPY, COMBINATION; FEMALE; FOLLOW-UP STUDIES; FOOT; GANGRENE; GLUCOCORTICOIDS; HUMANS; IMMUNOGLOBULINS, INTRAVENOUS; LUPUS ERYTHEMATOSUS, SYSTEMIC; THROMBOCYTOPENIA; VASCULITIS;

EID: 0030470024     PISSN: 0392856X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. CORVETTA A, DELLA-BITTA R, GABRIELLI A, SPAETH PJ, DANIELI G: Use of high-dose intravenous immunoglobulin in systemic lupus erythematosus: report of three cases. Clin Exp Rheumatol 1989; 7: 295-9.
2. AKASHI K, NAGASAWA K, MAYUMI T, YOKOTA E, OOCHI N, KUSABA T: Successful treatment of refractory systemic lupus erythematosus with intravenous immunoglobulins. J Rheumatol 1990; 17: 375-9.
3. MAIER WP, GORDON DS, HOWARD RF, SALEH MN, MILLER SB, LIEBERMAN JD, WOODLEE PM: Intravenous immunoglobulin therapy in systemic lupus erythematosus-associated thrombocytopenia. Arthritis Rheum 1990; 33: 1233-9.
4. COHEN MG, LI EK: Limited effects of intravenous IgG in treating systemic lupus erythematosus-associated thrombocytopenia (letter). Arthritis Rheum 1991; 34: 787-8.
5. BARRON KS, SHER MR, SILVERMAN ED: Intravenous immunoglobulin therapy: magic or black magic. J Rheumatol 1992; (Suppl. 33) 19: 94-7.
6. FRANCIONI C, GALEAZZI M, FIORAVANTI A, GELLI R, MEGALE F. MARCOLONGO R: Long term I.V. Ig treatment in systemic lupus erythematosus. Clin Exp Rheumatol 1994; 12: 163-8.
7. DUHEM C, DICATO MA, RIES F: Side-effects of intravenous immune globulins. Clin Exp Immunol 1994; 97 (Suppl. 1): 79-83.
8. JORDAN SC: Intravenous gamma-globulin therapy in systemic lupus erythematosus and immune complex disease. Clin Immunol Immunopathol 1989; 53: S164-9.
9. JORDAN SC, TOYODA M: Treatment of autoimmune diseases and systemic vasculitis with pooled human intravenous immune globulin. Clin Exp Immunol 1994; 97 (Suppl. 1): 31-8.
10. PRIEUR AM, ADLEFF A, DEBRE M, BOULATE P, GRISCELLI C: High dose immunoglobulin therapy in severe juvenile chronic arthritis: long-term follow-up in 16 patients. Clin Exp Rheumatol 1990; 8: 603-9.
11. UZIEL Y, LAXER R, SCHNEIDER R, SILVERMAN E: Intravenous immunoglobulin therapy in systemic juvenile rheumatoid arthritis (abstr). Arthritis Rheum 1993; 36 (Suppl.): S60.
12. WOODRUFF RK, GRIGG AP, FIRKIN FC, SMITH IL: Fatal thrombotic events during treatment of autoimmune thrombocytopenia with intravenous immunoglobulin in elderly patients. Lancet 1986; 2: 217-8.
13. SILBERT PL, KNEZEVIC WV, BRIDGE DT: Cerebral infarction complicating intravenous immunoglobulin therapy for polyneuritis cranialis. Neurology 1992; 42: 257-8.
14. REINHART WH, BERCHTOLD PE: Effect of high-dose intravenous immunoglobulin therapy on blood rheology. Lancet 1992; 339: 662-4.
15. DALAKAS MC: High-dose intravenous immunoglobulin and serum viscosity. Neurology 1994; 44: 223-6.
16. TAN EM, COHEN AS, FRIES JF,MASI AT, MCSHANE DJ, ROTHFIELD NF, SCHALLER JG, TALAL N, WINCHESTER RJ: The 1982 re vised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982; 25: 1271-7.
17. NATIONAL INSTITUTE OF HEALTH CONSENSUS CONFERENCE: Intravenous immunoglobulin: Prevention and treatment of disease. JAMA 1990;264:3189-93.
18. BARTON JC, HERRERA GA, GALLA JH, BERTOLI LF, WORK J, KOOPMAN WJ: Acute cryoglobulinemic renal failure after intravenous infusion of gamma globulin. Am J Med 1987; 82: 624-9.
19. LIN RY, RACIS SP: In vivo reduction of circulating C1q binding immune complexes by intravenous gammaglobulin administration. Int Archs Allergy Appl Immun 1986;79:286-90.
20. LIN CY, HSU HC, CHIANG H: Improvement of histological and immunological change in steroid and immunosuppressive drug-resistant lupus nephritis by high-dose intravenous gamma globulin. Nephron 1989; 53: 303-10.
21. HACHIMI-IDRISSI S, DE SCHEPPER J, DEWAELE M, DAB I, OTTEN J: Type HI allergic reaction after infusion of immunoglobulin (Letter). Lancet 1990; 336: 55.